These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18737710)

  • 1. CLINICAL ASPECTS OF THE FASTING TREATMENT OF DIABETES.
    Rowe AH
    Cal State J Med; 1918 Sep; 16(9):433-8. PubMed ID: 18737710
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes, driving and fasting during Ramadan: the interplay between secular and religious law.
    Ghouri N; Hussain S; Mohammed R; Beshyah SA; Chowdhury TA; Sattar N; Sheikh A
    BMJ Open Diabetes Res Care; 2018; 6(1):e000520. PubMed ID: 29892339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPISE and other fasting indexes of insulin resistance: risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspects.
    Cederholm J; Zethelius B
    Ups J Med Sci; 2019 Nov; 124(4):265-272. PubMed ID: 31694444
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing how we risk-categorise in Ramadan: Does the IDF-DAR scoring system achieve the requirements for people with diabetes internationally?
    Ghouri N; Hussain S; Ahmed SH; Beshyah SA; Rashid R; Al-Ozairi E; Waqar S; Dabhad A; Mohammed R
    Diabetes Res Clin Pract; 2021 May; 175():108835. PubMed ID: 33901626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Rasmussen ML; Chambless LE; Howard G; Cooper LS; Schmidt MI; Heiss G
    Diabetes Care; 1999 Jul; 22(7):1077-83. PubMed ID: 10388971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramadan fasting and diabetes 2019: The year in review.
    Beshyah SA; Ali KF; Hafidh K; Hajjaji IM
    Diabetes Res Clin Pract; 2021 Feb; 172():108593. PubMed ID: 33316310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus.
    Ibrahim M; Davies MJ; Ahmad E; Annabi FA; Eckel RH; Ba-Essa EM; El Sayed NA; Hess Fischl A; Houeiss P; Iraqi H; Khochtali I; Khunti K; Masood SN; Mimouni-Zerguini S; Shera S; Tuomilehto J; Umpierrez GE
    BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32366501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes and Ramadan : consequences of fasting and practical aspects of management].
    Bessemans S; Paquot N
    Rev Med Liege; 2017 Oct; 72(10):439-443. PubMed ID: 29058835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Pandemic and Ramadan Fasting among Patients with Type 2 Diabetes Mellitus.
    Zaina A; Tarabeih W; Abid A; Kassem S
    Isr Med Assoc J; 2021 Apr; 23(4):203-207. PubMed ID: 33899349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes.
    Nielsen MF; Nyholm B; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Rizza RA; Schmitz O
    Diabetes; 2000 Dec; 49(12):2135-41. PubMed ID: 11118017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramadan fasting in diabetes-exercise in problem-solving.
    Saboo B
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S713-S714. PubMed ID: 28943269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in serum electrolytes. XVII. Some clinical aspects.
    SUNDERMAN FW
    Am J Clin Pathol; 1951 Apr; 21(4):319-331. PubMed ID: 14818988
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus.
    Grajower MM; Horne BD
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31003482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Ramadan: review of the literature.
    Benaji B; Mounib N; Roky R; Aadil N; Houti IE; Moussamih S; Maliki S; Gressier B; El Ghomari H
    Diabetes Res Clin Pract; 2006 Aug; 73(2):117-25. PubMed ID: 16647781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence.
    Al Sifri S; Rizvi K
    Diabetes Ther; 2016 Jun; 7(2):221-40. PubMed ID: 27091198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia.
    Greenfield M; Kolterman O; Olefsky J; Reaven GM
    Diabetologia; 1980 Jun; 18(6):441-6. PubMed ID: 7418956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study.
    Nowak KM; Rdzanek-Pikus M; Romanowska-Próchnicka K; Nowakowska-Płaza A; Papierska L
    Rheumatology (Oxford); 2021 Jun; 60(6):2842-2851. PubMed ID: 33254223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in fasting patterns during Ramadan, and associated clinical outcomes in adults with type 2 diabetes: A narrative review of epidemiological studies over the last 20 years.
    Hassanein MM; Hanif W; Malek R; Jabbar A
    Diabetes Res Clin Pract; 2021 Feb; 172():108584. PubMed ID: 33307133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
    Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
    BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.